Fieldpoint Private Securities, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Fieldpoint Private Securities, LLC

  • $344 Million
  • Q2 2022

A detailed history of Fieldpoint Private Securities, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Fieldpoint Private Securities, LLC holds 25 shares of REGN stock, worth $26,006. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25
Previous 54 53.7%
Holding current value
$26,006
Previous $38,000 60.53%
% of portfolio
0.0%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022
SELL
$548.35 - $738.84 $15,902 - $21,426
-29 Reduced 53.7%
25 $15,000
Q1 2022

Apr 07, 2022
BUY
$595.12 - $698.43 $2,975 - $3,492
5 Added 10.2%
54 $38,000
Q4 2021

Jan 24, 2022
BUY
$543.48 - $670.97 $8,152 - $10,064
15 Added 44.12%
49 $31,000
Q3 2021

Nov 12, 2021
BUY
$574.03 - $680.96 $2,296 - $2,723
4 Added 13.33%
34 $21,000
Q2 2021

Aug 12, 2021
SELL
$472.8 - $558.54 $33,096 - $39,097
-70 Reduced 70.0%
30 $18,000
Q1 2021

Apr 23, 2021
SELL
$446.73 - $548.2 $181,372 - $222,569
-406 Reduced 80.24%
100 $47,000
Q4 2020

Jan 28, 2021
BUY
$478.3 - $607.98 $11,957 - $15,199
25 Added 5.2%
506 $244,000
Q3 2020

Oct 23, 2020
SELL
$544.75 - $658.21 $64,825 - $78,326
-119 Reduced 19.83%
481 $269,000
Q2 2020

Aug 14, 2020
BUY
$493.32 - $643.92 $58,211 - $75,982
118 Added 24.48%
600 $374,000
Q1 2020

May 11, 2020
SELL
$336.18 - $494.43 $71,606 - $105,313
-213 Reduced 30.65%
482 $235,000
Q4 2019

Feb 10, 2020
SELL
$274.13 - $376.51 $5,208 - $7,153
-19 Reduced 2.66%
695 $261,000
Q3 2019

Nov 07, 2019
SELL
$273.46 - $318.39 $13,946 - $16,237
-51 Reduced 6.67%
714 $198,000
Q2 2019

Aug 14, 2019
BUY
$299.6 - $414.82 $115,046 - $159,290
384 Added 100.79%
765 $239,000
Q1 2019

May 13, 2019
BUY
$372.08 - $439.57 $10,418 - $12,307
28 Added 7.93%
381 $156,000
Q4 2018

Feb 11, 2019
SELL
$335.82 - $403.04 $32,910 - $39,497
-98 Reduced 21.73%
353 $132,000
Q3 2018

Nov 15, 2018
SELL
$351.14 - $408.51 $54,426 - $63,319
-155 Reduced 25.58%
451 $182,000
Q2 2018

Aug 06, 2018
BUY
$284.6 - $344.99 $7,115 - $8,624
25 Added 4.3%
606 $209,000
Q1 2018

May 08, 2018
SELL
$315.82 - $393.78 $65,690 - $81,906
-208 Reduced 26.36%
581 $200,000
Q4 2017

Feb 15, 2018
SELL
$358.63 - $469.95 $83,202 - $109,028
-232 Reduced 22.72%
789 $297,000
Q3 2017

Nov 15, 2017
BUY
$431.38 - $504.0 $326,123 - $381,024
756 Added 285.28%
1,021 $457,000
Q2 2017

Aug 14, 2017
BUY
N/A
265
265 $130,000

Others Institutions Holding REGN

# of Institutions
1,463
Shares Held
84.5M
Call Options Held
907K
Put Options Held
1.3M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $112B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Fieldpoint Private Securities, LLC Portfolio

Follow Fieldpoint Private Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fieldpoint Private Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fieldpoint Private Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email